Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$0.42 - $0.72 $29,214 - $50,081
69,558 Added 3.1%
2,311,047 $1.46 Million
Q3 2023

Nov 13, 2023

BUY
$0.6 - $1.53 $33,021 - $84,203
55,035 Added 2.52%
2,241,489 $1.34 Million
Q2 2023

Aug 11, 2023

SELL
$1.05 - $1.63 $23,438 - $36,384
-22,322 Reduced 1.01%
2,186,454 $2.47 Million
Q1 2023

May 15, 2023

SELL
$1.2 - $2.73 $47,383 - $107,796
-39,486 Reduced 1.76%
2,208,776 $2.98 Million
Q4 2022

Feb 13, 2023

BUY
$1.71 - $3.61 $48,846 - $103,119
28,565 Added 1.29%
2,248,262 $4.18 Million
Q3 2022

Nov 14, 2022

BUY
$1.9 - $8.63 $164,950 - $749,222
86,816 Added 4.07%
2,219,697 $5.46 Million
Q2 2022

Aug 12, 2022

BUY
$2.13 - $9.01 $480,504 - $2.03 Million
225,589 Added 11.83%
2,132,881 $5.2 Million
Q1 2022

May 13, 2022

SELL
$6.28 - $15.59 $308,932 - $766,918
-49,193 Reduced 2.51%
1,907,292 $15.2 Million
Q4 2021

Feb 08, 2022

SELL
$14.7 - $28.67 $679,345 - $1.32 Million
-46,214 Reduced 2.31%
1,956,485 $29.9 Million
Q3 2021

Nov 15, 2021

SELL
$24.31 - $33.6 $2.07 Million - $2.87 Million
-85,355 Reduced 4.09%
2,002,699 $56.9 Million
Q2 2021

Aug 13, 2021

BUY
$26.09 - $40.4 $14.4 Million - $22.3 Million
550,964 Added 35.84%
2,088,054 $70.4 Million
Q1 2021

May 12, 2021

BUY
$33.06 - $56.93 $447,169 - $770,035
13,526 Added 0.89%
1,537,090 $58.7 Million
Q4 2020

Feb 11, 2021

BUY
$39.09 - $57.4 $1.12 Million - $1.65 Million
28,696 Added 1.92%
1,523,564 $63.7 Million
Q3 2020

Nov 16, 2020

BUY
$28.43 - $44.67 $6 Million - $9.43 Million
211,179 Added 16.45%
1,494,868 $64.8 Million
Q2 2020

Aug 14, 2020

BUY
$11.71 - $30.29 $1.57 Million - $4.05 Million
133,826 Added 11.64%
1,283,689 $38.9 Million
Q1 2020

May 14, 2020

BUY
$7.64 - $27.5 $135,785 - $488,757
17,773 Added 1.57%
1,149,863 $15.7 Million
Q4 2019

Feb 14, 2020

SELL
$15.02 - $20.57 $114,872 - $157,319
-7,648 Reduced 0.67%
1,132,090 $18.3 Million
Q3 2019

Nov 13, 2019

BUY
$18.85 - $27.5 $3.28 Million - $4.78 Million
173,836 Added 18.0%
1,139,738 $22 Million
Q2 2019

Aug 13, 2019

BUY
$17.37 - $26.27 $1.13 Million - $1.71 Million
65,134 Added 7.23%
965,902 $22.7 Million
Q1 2019

May 13, 2019

BUY
$10.65 - $25.75 $1.13 Million - $2.74 Million
106,274 Added 13.38%
900,768 $21.1 Million
Q4 2018

Feb 12, 2019

BUY
$9.26 - $16.38 $65,875 - $116,527
7,114 Added 0.9%
794,494 $8.79 Million
Q3 2018

Nov 14, 2018

BUY
$7.54 - $18.31 $376,547 - $914,401
49,940 Added 6.77%
787,380 $13.2 Million
Q2 2018

Sep 18, 2018

SELL
$4.87 - $8.42 $15,920 - $27,524
-3,269 Reduced 0.44%
737,440 $5.42 Million
Q2 2018

Aug 14, 2018

BUY
$4.87 - $8.42 $1.33 Million - $2.3 Million
273,067 Added 58.39%
740,709 $5.44 Million
Q1 2018

May 09, 2018

SELL
$4.69 - $10.05 $16,175 - $34,662
-3,449 Reduced 0.73%
467,642 $2.19 Million
Q4 2017

Feb 14, 2018

BUY
$7.86 - $9.99 $234,408 - $297,931
29,823 Added 6.76%
471,091 $4.28 Million
Q3 2017

Nov 13, 2017

BUY
$8.89 - $10.4 $3.92 Million - $4.59 Million
441,268
441,268 $4.14 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.